Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

TFFP

TFF Pharmaceuticals (TFFP)

TFF Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TFFP
DataHoraFonteTítuloCódigoCompanhia
06/02/202518:05PR Newswire (US)TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC DeregistrationNASDAQ:TFFPTFF Pharmaceuticals Inc
04/02/202518:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TFFPTFF Pharmaceuticals Inc
03/02/202518:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
23/12/202408:50Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
11/12/202418:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
20/11/202419:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TFFPTFF Pharmaceuticals Inc
14/11/202418:20Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:TFFPTFF Pharmaceuticals Inc
14/11/202418:15GlobeNewswire Inc.TFF Pharmaceuticals Announces It Will Wind Down OperationsNASDAQ:TFFPTFF Pharmaceuticals Inc
26/09/202408:00GlobeNewswire Inc.TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug DeliveryNASDAQ:TFFPTFF Pharmaceuticals Inc
11/09/202408:00GlobeNewswire Inc.TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVIDNASDAQ:TFFPTFF Pharmaceuticals Inc
10/09/202408:00GlobeNewswire Inc.TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal ImmunizationNASDAQ:TFFPTFF Pharmaceuticals Inc
03/09/202409:00GlobeNewswire Inc.TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:TFFPTFF Pharmaceuticals Inc
14/08/202417:05GlobeNewswire Inc.TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:TFFPTFF Pharmaceuticals Inc
08/07/202418:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
14/06/202417:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TFFPTFF Pharmaceuticals Inc
17/05/202417:07Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TFFPTFF Pharmaceuticals Inc
07/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TFFPTFF Pharmaceuticals Inc
08/12/202318:52Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:TFFPTFF Pharmaceuticals Inc
04/12/202319:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
21/11/202318:41Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TFFPTFF Pharmaceuticals Inc
04/10/202317:10Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TFFPTFF Pharmaceuticals Inc
17/08/202317:01GlobeNewswire Inc.TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment OptionNASDAQ:TFFPTFF Pharmaceuticals Inc
15/08/202307:00GlobeNewswire Inc.TFF Pharmaceuticals Prices $5 Million Public Offering of Common StockNASDAQ:TFFPTFF Pharmaceuticals Inc
27/06/202307:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TFFPTFF Pharmaceuticals Inc
23/06/202318:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TFFPTFF Pharmaceuticals Inc
11/05/202317:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TFFPTFF Pharmaceuticals Inc
13/03/202317:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TFFPTFF Pharmaceuticals Inc
13/02/202318:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TFFPTFF Pharmaceuticals Inc
27/12/202211:28Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TFFPTFF Pharmaceuticals Inc
15/12/202219:02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:TFFPTFF Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TFFP